Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


16.04.2018

1 BMC Cancer
2 Clin Cancer Res
2 Gynecol Oncol
1 Obstet Gynecol
1 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. TILBURY KB, Campbell KR, Eliceiri KW, Salih SM, et al
    Stromal alterations in ovarian cancers via wavelength dependent Second Harmonic Generation microscopy and optical scattering.
    BMC Cancer. 2017;17:102.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  2. BELUR NAGARAJ A, Kovalenko O, Avelar RA, Joseph P, et al
    Mitotic Exit dysfunction through the deregulation of APC/C characterizes cisplatin resistant state in epithelial ovarian cancer.
    Clin Cancer Res. 2018 Apr 13. pii: 1078-0432.CCR-17-2885.
    PubMed     Text format     Abstract available

  3. ISON G, Howie LJ, Amiri-Kordestani L, Zhang L, et al
    FDA Approval Summary: Niraparib for the maintenance treatment of patients with recurrent ovarian cancer in response to platinum-based chemotherapy.
    Clin Cancer Res. 2018 Apr 12. pii: 1078-0432.CCR-18-0042.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  4. UYAR D, Neary J, Monroe A, Nugent M, et al
    Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Gynecol Oncol. 2018 Apr 10. pii: S0090-8258(18)30239.
    PubMed     Text format     Abstract available

  5. LIU J, Nicum S, Reichardt P, Croitoru K, et al
    Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer.
    Gynecol Oncol. 2018 Apr 4. pii: S0090-8258(18)30238.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  6. MENON U, Karpinskyj C, Gentry-Maharaj A
    Ovarian Cancer Prevention and Screening.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002580.
    PubMed     Text format     Abstract available


    Oncogene

  7. DORAYAPPAN KDP, Wanner R, Wallbillich JJ, Saini U, et al
    Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.
    Oncogene. 2018 Apr 11. pii: 10.1038/s41388-018-0189.
    PubMed     Text format     Abstract available


    PLoS One

  8. NEYT M, Vlayen J, Devriese S, Camberlin C, et al
    First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis.
    PLoS One. 2018;13:e0195134.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: